Demographics, comorbidities (hypertension, diabetes, dyslipidemia), prior cardiovascular history (previous MI, PCI), hemodynamic parameters, laboratory markers (troponin, creatinine, NT-proBNP), coronary anatomy (culprit lesion, number of vessels affected), and treatment variables (PCI characteristics, thrombus aspiration, mechanical circulatory support use). This evidence concerns the gene NPPB and Hypertension.